Global Influenza Virus Vaccine (H1N1) Market Research Report 2020

ID: 1208602 26 May 2020 Region : Global 116 Pages
Covid-19

COVID-19

Understand the influence of COVID-19 on the Influenza Virus Vaccine H1N1 Market with our analysts monitoring the situation across the globe.

The global Influenza Virus Vaccine (H1N1) market is valued at US$ xx million in 2019 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. This report focuses on Influenza Virus Vaccine (H1N1) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Influenza Virus Vaccine (H1N1) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc. Market Segment Analysis The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the Influenza Virus Vaccine (H1N1) market is segmented into Intramuscular Vaccine Nasal Spray Vaccine Segment by Application 3 To 10 Years Old 10 To 18 Years Old Above 18 Years Old Other Global Influenza Virus Vaccine (H1N1) Market: Regional Analysis The Influenza Virus Vaccine (H1N1) market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026. The key regions covered in the Influenza Virus Vaccine (H1N1) market report are: North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE Global Influenza Virus Vaccine (H1N1) Market: Competitive Analysis This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019. The major players in global Influenza Virus Vaccine (H1N1) market include: CSL NVS(Novartis) Sanofi Pasteur Medimmune GSK Baxter Beijing Kexing Bio-Vaccine Hualan Bio-Vaccine Changchun Changsheng Bio-Technology Beijing Tiantan Bio-Products Jiangsu Yanshen Bio-Technology Zhejiang Tianyuan Bio-Pharmaceutical Dalian Yalifeng Bio-Pharmaceutical

1 Influenza Virus Vaccine (H1N1) Market Overview 1.1 Product Overview and Scope of Influenza Virus Vaccine (H1N1) 1.2 Influenza Virus Vaccine (H1N1) Segment by Type 1.2.1 Global Influenza Virus Vaccine (H1N1) Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Intramuscular Vaccine 1.2.3 Nasal Spray Vaccine 1.3 Influenza Virus Vaccine (H1N1) Segment by Application 1.3.1 Influenza Virus Vaccine (H1N1) Sales Comparison by Application: 2020 VS 2026 1.3.2 3 To 10 Years Old 1.3.3 10 To 18 Years Old 1.3.4 Above 18 Years Old 1.3.5 Other 1.4 Global Influenza Virus Vaccine (H1N1) Market Size Estimates and Forecasts 1.4.1 Global Influenza Virus Vaccine (H1N1) Revenue 2015-2026 1.4.2 Global Influenza Virus Vaccine (H1N1) Sales 2015-2026 1.4.3 Influenza Virus Vaccine (H1N1) Market Size by Region: 2020 Versus 2026 2 Global Influenza Virus Vaccine (H1N1) Market Competition by Manufacturers 2.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Manufacturers (2015-2020) 2.2 Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers (2015-2020) 2.3 Global Influenza Virus Vaccine (H1N1) Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Influenza Virus Vaccine (H1N1) Manufacturing Sites, Area Served, Product Type 2.5 Influenza Virus Vaccine (H1N1) Market Competitive Situation and Trends 2.5.1 Influenza Virus Vaccine (H1N1) Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Influenza Virus Vaccine (H1N1) Players (Opinion Leaders) 3 Influenza Virus Vaccine (H1N1) Retrospective Market Scenario by Region 3.1 Global Influenza Virus Vaccine (H1N1) Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Influenza Virus Vaccine (H1N1) Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country 3.3.1 North America Influenza Virus Vaccine (H1N1) Sales by Country 3.3.2 North America Influenza Virus Vaccine (H1N1) Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country 3.4.1 Europe Influenza Virus Vaccine (H1N1) Sales by Country 3.4.2 Europe Influenza Virus Vaccine (H1N1) Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Influenza Virus Vaccine (H1N1) Market Facts & Figures by Region 3.5.1 Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region 3.5.2 Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country 3.6.1 Latin America Influenza Virus Vaccine (H1N1) Sales by Country 3.6.2 Latin America Influenza Virus Vaccine (H1N1) Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country 3.7.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country 3.7.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Influenza Virus Vaccine (H1N1) Historic Market Analysis by Type 4.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2015-2020) 4.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2015-2020) 4.3 Global Influenza Virus Vaccine (H1N1) Price Market Share by Type (2015-2020) 4.4 Global Influenza Virus Vaccine (H1N1) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Influenza Virus Vaccine (H1N1) Historic Market Analysis by Application 5.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2015-2020) 5.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2015-2020) 5.3 Global Influenza Virus Vaccine (H1N1) Price by Application (2015-2020) 6 Company Profiles and Key Figures in Influenza Virus Vaccine (H1N1) Business 6.1 CSL 6.1.1 Corporation Information 6.1.2 CSL Description, Business Overview and Total Revenue 6.1.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) 6.1.4 CSL Products Offered 6.1.5 CSL Recent Development 6.2 NVS(Novartis) 6.2.1 NVS(Novartis) Influenza Virus Vaccine (H1N1) Production Sites and Area Served 6.2.2 NVS(Novartis) Description, Business Overview and Total Revenue 6.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) 6.2.4 NVS(Novartis) Products Offered 6.2.5 NVS(Novartis) Recent Development 6.3 Sanofi Pasteur 6.3.1 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Production Sites and Area Served 6.3.2 Sanofi Pasteur Description, Business Overview and Total Revenue 6.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Sanofi Pasteur Products Offered 6.3.5 Sanofi Pasteur Recent Development 6.4 Medimmune 6.4.1 Medimmune Influenza Virus Vaccine (H1N1) Production Sites and Area Served 6.4.2 Medimmune Description, Business Overview and Total Revenue 6.4.3 Medimmune Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Medimmune Products Offered 6.4.5 Medimmune Recent Development 6.5 GSK 6.5.1 GSK Influenza Virus Vaccine (H1N1) Production Sites and Area Served 6.5.2 GSK Description, Business Overview and Total Revenue 6.5.3 GSK Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) 6.5.4 GSK Products Offered 6.5.5 GSK Recent Development 6.6 Baxter 6.6.1 Baxter Influenza Virus Vaccine (H1N1) Production Sites and Area Served 6.6.2 Baxter Description, Business Overview and Total Revenue 6.6.3 Baxter Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Baxter Products Offered 6.6.5 Baxter Recent Development 6.7 Beijing Kexing Bio-Vaccine 6.6.1 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Production Sites and Area Served 6.6.2 Beijing Kexing Bio-Vaccine Description, Business Overview and Total Revenue 6.6.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Beijing Kexing Bio-Vaccine Products Offered 6.7.5 Beijing Kexing Bio-Vaccine Recent Development 6.8 Hualan Bio-Vaccine 6.8.1 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Production Sites and Area Served 6.8.2 Hualan Bio-Vaccine Description, Business Overview and Total Revenue 6.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Hualan Bio-Vaccine Products Offered 6.8.5 Hualan Bio-Vaccine Recent Development 6.9 Changchun Changsheng Bio-Technology 6.9.1 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Production Sites and Area Served 6.9.2 Changchun Changsheng Bio-Technology Description, Business Overview and Total Revenue 6.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Changchun Changsheng Bio-Technology Products Offered 6.9.5 Changchun Changsheng Bio-Technology Recent Development 6.10 Beijing Tiantan Bio-Products 6.10.1 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Production Sites and Area Served 6.10.2 Beijing Tiantan Bio-Products Description, Business Overview and Total Revenue 6.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Beijing Tiantan Bio-Products Products Offered 6.10.5 Beijing Tiantan Bio-Products Recent Development 6.11 Jiangsu Yanshen Bio-Technology 6.11.1 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Production Sites and Area Served 6.11.2 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Description, Business Overview and Total Revenue 6.11.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) 6.11.4 Jiangsu Yanshen Bio-Technology Products Offered 6.11.5 Jiangsu Yanshen Bio-Technology Recent Development 6.12 Zhejiang Tianyuan Bio-Pharmaceutical 6.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Production Sites and Area Served 6.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Description, Business Overview and Total Revenue 6.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) 6.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Products Offered 6.12.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Development 6.13 Dalian Yalifeng Bio-Pharmaceutical 6.13.1 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Production Sites and Area Served 6.13.2 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Description, Business Overview and Total Revenue 6.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) 6.13.4 Dalian Yalifeng Bio-Pharmaceutical Products Offered 6.13.5 Dalian Yalifeng Bio-Pharmaceutical Recent Development 6.14 Sinopharm 6.14.1 Sinopharm Influenza Virus Vaccine (H1N1) Production Sites and Area Served 6.14.2 Sinopharm Influenza Virus Vaccine (H1N1) Description, Business Overview and Total Revenue 6.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) 6.14.4 Sinopharm Products Offered 6.14.5 Sinopharm Recent Development 7 Influenza Virus Vaccine (H1N1) Manufacturing Cost Analysis 7.1 Influenza Virus Vaccine (H1N1) Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Influenza Virus Vaccine (H1N1) 7.4 Influenza Virus Vaccine (H1N1) Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Influenza Virus Vaccine (H1N1) Distributors List 8.3 Influenza Virus Vaccine (H1N1) Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Influenza Virus Vaccine (H1N1) Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Influenza Virus Vaccine (H1N1) by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Influenza Virus Vaccine (H1N1) by Type (2021-2026) 10.2 Influenza Virus Vaccine (H1N1) Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Influenza Virus Vaccine (H1N1) by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Influenza Virus Vaccine (H1N1) by Application (2021-2026) 10.3 Influenza Virus Vaccine (H1N1) Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Influenza Virus Vaccine (H1N1) by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Influenza Virus Vaccine (H1N1) by Region (2021-2026) 10.4 North America Influenza Virus Vaccine (H1N1) Estimates and Projections (2021-2026) 10.5 Europe Influenza Virus Vaccine (H1N1) Estimates and Projections (2021-2026) 10.6 Asia Pacific Influenza Virus Vaccine (H1N1) Estimates and Projections (2021-2026) 10.7 Latin America Influenza Virus Vaccine (H1N1) Estimates and Projections (2021-2026) 10.8 Middle East and Africa Influenza Virus Vaccine (H1N1) Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) Growth Rate Comparison by Type (2015-2026) Table 2. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) Comparison by Application: 2020 VS 2026 Table 3. Global Influenza Virus Vaccine (H1N1) Market Size by Type (K Doses) (US$ Million) (2020 VS 2026) Table 4. Global Key Influenza Virus Vaccine (H1N1) Manufacturers Covered in This Study Table 5. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Manufacturers (2015-2020) Table 6. Global Influenza Virus Vaccine (H1N1) Sales Share by Manufacturers (2015-2020) Table 7. Global Influenza Virus Vaccine (H1N1) Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Influenza Virus Vaccine (H1N1) Average Price (US$/Dose) of Key Manufacturers (2015-2020) Table 10. Manufacturers Influenza Virus Vaccine (H1N1) Sales Sites and Area Served Table 11. Manufacturers Influenza Virus Vaccine (H1N1) Product Types Table 12. Global Influenza Virus Vaccine (H1N1) Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Influenza Virus Vaccine (H1N1) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Virus Vaccine (H1N1) as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Influenza Virus Vaccine (H1N1) Players Table 16. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Region (2015-2020) Table 17. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2015-2020) Table 18. Global Influenza Virus Vaccine (H1N1) Revenue (Million US$) by Region (2015-2020) Table 19. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2015-2020) Table 20. North America Influenza Virus Vaccine (H1N1) Sales by Country (2015-2020) (K Doses) Table 21. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2015-2020) Table 22. North America Influenza Virus Vaccine (H1N1) Revenue by Country (2015-2020) (US$ Million) Table 23. North America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2015-2020) Table 24. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2015-2020) (K Doses) Table 25. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2015-2020) Table 26. Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2015-2020) (K Doses) Table 29. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2015-2020) Table 32. Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2015-2020) (K Doses) Table 33. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2015-2020) Table 34. Latin America Influenza Virus Vaccine (H1N1) Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2015-2020) (K Doses) Table 37. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2015-2020) Table 40. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Type (2015-2020) Table 41. Global Influenza Virus Vaccine (H1N1) Sales Share by Type (2015-2020) Table 42. Global Influenza Virus Vaccine (H1N1) Revenue (Million US$) by Type (2015-2020) Table 43. Global Influenza Virus Vaccine (H1N1) Revenue Share by Type (2015-2020) Table 44. Global Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Type (2015-2020) Table 45. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Application (2015-2020) Table 46. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2015-2020) Table 47. Global Influenza Virus Vaccine (H1N1) Sales Growth Rate by Application (2015-2020) Table 48. CSL Influenza Virus Vaccine (H1N1) Corporation Information Table 49. CSL Description and Business Overview Table 50. CSL Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) Table 51. CSL Main Product Table 52. CSL Recent Development Table 53. NVS(Novartis) Influenza Virus Vaccine (H1N1) Corporation Information Table 54. NVS(Novartis) Corporation Information Table 55. NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) Table 56. NVS(Novartis) Main Product Table 57. NVS(Novartis) Recent Development Table 58. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Corporation Information Table 59. Sanofi Pasteur Corporation Information Table 60. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) Table 61. Sanofi Pasteur Main Product Table 62. Sanofi Pasteur Recent Development Table 63. Medimmune Influenza Virus Vaccine (H1N1) Corporation Information Table 64. Medimmune Corporation Information Table 65. Medimmune Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) Table 66. Medimmune Main Product Table 67. Medimmune Recent Development Table 68. GSK Influenza Virus Vaccine (H1N1) Corporation Information Table 69. GSK Corporation Information Table 70. GSK Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) Table 71. GSK Main Product Table 72. GSK Recent Development Table 73. Baxter Influenza Virus Vaccine (H1N1) Corporation Information Table 74. Baxter Corporation Information Table 75. Baxter Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) Table 76. Baxter Main Product Table 77. Baxter Recent Development Table 78. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Corporation Information Table 79. Beijing Kexing Bio-Vaccine Corporation Information Table 80. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) Table 81. Beijing Kexing Bio-Vaccine Main Product Table 82. Beijing Kexing Bio-Vaccine Recent Development Table 83. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Corporation Information Table 84. Hualan Bio-Vaccine Corporation Information Table 85. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) Table 86. Hualan Bio-Vaccine Main Product Table 87. Hualan Bio-Vaccine Recent Development Table 88. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Corporation Information Table 89. Changchun Changsheng Bio-Technology Corporation Information Table 90. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) Table 91. Changchun Changsheng Bio-Technology Main Product Table 92. Changchun Changsheng Bio-Technology Recent Development Table 93. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Corporation Information Table 94. Beijing Tiantan Bio-Products Corporation Information Table 95. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) Table 96. Beijing Tiantan Bio-Products Main Product Table 97. Beijing Tiantan Bio-Products Recent Development Table 98. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Corporation Information Table 99. Jiangsu Yanshen Bio-Technology Corporation Information Table 100. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) Table 101. Jiangsu Yanshen Bio-Technology Main Product Table 102. Jiangsu Yanshen Bio-Technology Recent Development Table 103. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Corporation Information Table 104. Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information Table 105. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) Table 106. Zhejiang Tianyuan Bio-Pharmaceutical Main Product Table 107. Zhejiang Tianyuan Bio-Pharmaceutical Recent Development Table 108. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Corporation Information Table 109. Dalian Yalifeng Bio-Pharmaceutical Corporation Information Table 110. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) Table 111. Dalian Yalifeng Bio-Pharmaceutical Main Product Table 112. Dalian Yalifeng Bio-Pharmaceutical Recent Development Table 113. Sinopharm Influenza Virus Vaccine (H1N1) Corporation Information Table 114. Sinopharm Corporation Information Table 115. Sinopharm Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) Table 116. Sinopharm Main Product Table 117. Sinopharm Recent Development Table 118. Sales Base and Market Concentration Rate of Raw Material Table 119. Key Suppliers of Raw Materials Table 120. Influenza Virus Vaccine (H1N1) Distributors List Table 121. Influenza Virus Vaccine (H1N1) Customers List Table 122. Market Key Trends Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 124. Key Challenges Table 125. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) Forecast by Type (2021-2026) Table 126. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Type (2021-2026) Table 127. Global Influenza Virus Vaccine (H1N1) Revenue (Million US$) Forecast by Type (2021-2026) Table 128. Global Influenza Virus Vaccine (H1N1) Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 129. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) Forecast by Application (2021-2026) Table 130. Global Influenza Virus Vaccine (H1N1) Revenue (Million US$) Forecast by Application (2021-2026) Table 131. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) Forecast by Region (2021-2026) Table 132. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Region (2021-2026) Table 133. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Region (2021-2026) (US$ Million) Table 134. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Region (2021-2026) Table 135. Research Programs/Design for This Report Table 136. Key Data Information from Secondary Sources Table 137. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Influenza Virus Vaccine (H1N1) Figure 2. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type: 2020 VS 2026 Figure 3. Intramuscular Vaccine Product Picture Figure 4. Nasal Spray Vaccine Product Picture Figure 5. Global Influenza Virus Vaccine (H1N1) Consumption Market Share by Application: 2020 VS 2026 Figure 6. 3 To 10 Years Old Figure 7. 10 To 18 Years Old Figure 8. Above 18 Years Old Figure 9. Other Figure 10. Global Influenza Virus Vaccine (H1N1) Market Size 2015-2026 (US$ Million) Figure 11. Global Influenza Virus Vaccine (H1N1) Sales Capacity (K Doses) (2015-2026) Figure 12. Global Influenza Virus Vaccine (H1N1) Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Influenza Virus Vaccine (H1N1) Sales Share by Manufacturers in 2020 Figure 14. Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers in 2019 Figure 15. The Global 5 and 10 Largest Players: Market Share by Influenza Virus Vaccine (H1N1) Revenue in 2019 Figure 16. Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 17. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2015-2020) Figure 18. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region in 2019 Figure 19. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2015-2020) Figure 20. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region in 2019 Figure 21. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2019 Figure 22. North America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country in 2019 Figure 23. U.S. Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 24. U.S. Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Canada Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 26. Canada Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2019 Figure 28. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Country in 2019 Figure 29. Germany Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 30. Germany Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. France Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 32. France Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. U.K. Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 34. U.K. Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Italy Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 36. Italy Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Russia Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 38. Russia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Market Share by Region in 2019 Figure 40. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue Market Share by Region in 2019 Figure 41. China Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 42. China Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Japan Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 44. Japan Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. South Korea Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 46. South Korea Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. India Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 48. India Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Australia Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 50. Australia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Taiwan Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 52. Taiwan Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Indonesia Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 54. Indonesia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Thailand Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 56. Thailand Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Malaysia Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 58. Malaysia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Philippines Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 60. Philippines Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Vietnam Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 62. Vietnam Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2019 Figure 64. Latin America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country in 2019 Figure 65. Mexico Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 66. Mexico Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Brazil Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 68. Brazil Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Argentina Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 70. Argentina Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2019 Figure 72. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue Market Share by Country in 2019 Figure 73. Turkey Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 74. Turkey Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Saudi Arabia Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 76. Saudi Arabia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. UAE Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) Figure 78. UAE Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Sales Market Share of Influenza Virus Vaccine (H1N1) by Type (2015-2020) Figure 80. Sales Market Share of Influenza Virus Vaccine (H1N1) by Type in 2019 Figure 81. Revenue Share of Influenza Virus Vaccine (H1N1) by Type (2015-2020) Figure 82. Revenue Market Share of Influenza Virus Vaccine (H1N1) by Type in 2019 Figure 83. Global Influenza Virus Vaccine (H1N1) Sales Growth by Type (2015-2020) (K Doses) Figure 84. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2015-2020) Figure 85. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application in 2019 Figure 86. Global Revenue Share of Influenza Virus Vaccine (H1N1) by Application (2015-2020) Figure 87. Global Revenue Share of Influenza Virus Vaccine (H1N1) by Application in 2020 Figure 88. CSL Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. NVS(Novartis) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Medimmune Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. GSK Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Baxter Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Beijing Kexing Bio-Vaccine Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Hualan Bio-Vaccine Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Changchun Changsheng Bio-Technology Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Beijing Tiantan Bio-Products Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Jiangsu Yanshen Bio-Technology Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Zhejiang Tianyuan Bio-Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Dalian Yalifeng Bio-Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. Sinopharm Total Revenue (US$ Million): 2019 Compared with 2018 Figure 102. Price Trend of Key Raw Materials Figure 103. Manufacturing Cost Structure of Influenza Virus Vaccine (H1N1) Figure 104. Manufacturing Process Analysis of Influenza Virus Vaccine (H1N1) Figure 105. Influenza Virus Vaccine (H1N1) Industrial Chain Analysis Figure 106. Channels of Distribution Figure 107. Distributors Profiles Figure 108. Porter's Five Forces Analysis Figure 109. North America Influenza Virus Vaccine (H1N1) Sales (K Doses) and Growth Rate Forecast (2021-2026) Figure 110. North America Influenza Virus Vaccine (H1N1) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 111. Europe Influenza Virus Vaccine (H1N1) Sales (K Doses) and Growth Rate Forecast (2021-2026) Figure 112. Europe Influenza Virus Vaccine (H1N1) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 113. Latin America Influenza Virus Vaccine (H1N1) Sales (K Doses) and Growth Rate Forecast (2021-2026) Figure 114. Latin America Influenza Virus Vaccine (H1N1) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 115. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales (K Doses) and Growth Rate Forecast (2021-2026) Figure 116. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 117. Asia Pacific Influenza Virus Vaccine (H1N1) Sales (K Doses) and Growth Rate Forecast (2021-2026) Figure 118. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 119. Bottom-up and Top-down Approaches for This Report Figure 120. Data Triangulation Figure 121. Key Executives Interviewed

Request COVID-19 Impact Analysis

We understand the economic repercussions of the pandemic and are dedicated towards helping our clients strategize with rapidly changing market scenario,
• Impact of COVID on supply/demand scenario, trade landscape & supply chain
• How market participants are preparing/strategizing to combat the impact
• How does the short-term & long-term scenario for Influenza Virus Vaccine H1N1 Market looks like

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Request Sample

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Request Discount

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Related Reports




Get 15 minutes of free Consultation When you request a Sample Report!

24/7 Research Report

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone:

+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Email: sale[email protected]

Request a Sample

Global Influenza Virus Vaccine (H1N1) Market Research Report 2020

Report ID :1208602

Published Date :26 May 2020

Category :Pharmaceuticals and Healthcare

Pages :116 Pages

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports

  • Data Security
  • Your data is safe and secure

  • Vast Report Database
  • We have more than 2 Million reports in our database

  • Client Focused
  • Personalized updates and 24*7 support

  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support

  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie

  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports


Every Sample Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology